ResearcherZhengzhou UniversityActive in the last 2 years

Yuqi Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5792-5723; OpenAlex author ID A5100400502. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Serum autoantibody signatures enable non-invasive early detection of pancreatic cancer. First author DOI 10.1016/j.pan.2025.11.017 ↗
Autoantibodies as Potential Liquid Biopsy Biomarker in Detection of Pancreatic Cancer: A Diagnostic Test Accuracy Review and Meta-Analysis. Co-author DOI 10.1111/sji.70012 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hua Ye · 2 shared papers, 2025–2026 · strength 0.49
- Paper Autoantibodies as Potential Liquid Biopsy Biomarker in Detection of Pancreatic Cancer: A Diagnostic Test Accuracy Revie… DOI 10.1111/sji.70012 ↗
- Paper Serum autoantibody signatures enable non-invasive early detection of pancreatic cancer. DOI 10.1016/j.pan.2025.11.017 ↗
Li Jiang Sun · 1 shared paper, 2026 · strength 0.24
- Paper Serum autoantibody signatures enable non-invasive early detection of pancreatic cancer. DOI 10.1016/j.pan.2025.11.017 ↗
Jicun Zhu · 1 shared paper, 2026 · strength 0.24
- Paper Serum autoantibody signatures enable non-invasive early detection of pancreatic cancer. DOI 10.1016/j.pan.2025.11.017 ↗
Tiandong Li · 1 shared paper, 2026 · strength 0.24
- Paper Serum autoantibody signatures enable non-invasive early detection of pancreatic cancer. DOI 10.1016/j.pan.2025.11.017 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.